Bots, editor, reviewer, Administrators
13,951
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
"ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism", | "ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism", | ||
"TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban", | "TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban", | ||
"EASE" : "Early Surgery versus Conventional Treatment in Infective Endocarditis", | |||
"TRISS" : "Transfusion Requirements in Septic Shock", | "TRISS" : "Transfusion Requirements in Septic Shock", | ||
"TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome", | "TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome", | ||
| Line 298: | Line 299: | ||
"CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study", | "CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study", | ||
"STICH" : "Surgical Treatment for Ischemic Heart Failure", | "STICH" : "Surgical Treatment for Ischemic Heart Failure", | ||
"HOPE-3" : "Heart Outcomes Prevention Evaluation-3", | |||
"ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade", | "ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade", | ||
"ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial", | "ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial", | ||